| Name | Title | Contact Details |
|---|
Cardinal Innovations Healthcare is the leading provider of managed care services in the U.S. Cardinal Innovations, the nations largest specialty health plan and the pioneer of a unique managed healthcare model, incorporates a community-based model of care management, a network of highly-skilled providers and local support partners to improve the health and wellness of plan members. Cardinal Innovations serves members through Medicaid, state and county-funded plans and supports a variety of initiatives for Veterans and their families through centralized call center services and other collaborative initiatives.
Since 1983, Schulman has provided the research community with IRB review services of the highest quality. In establishing the IRB, our founders sought to promote clinical research by helping to safeguard the rights and welfare of clinical research subjects. Schulman’s team of dedicated professionals seeks to provide timely, quality services based on the foundation of respect for persons, beneficence and justice. Through continuous quality improvement and rigorous training on human subject protection, Schulman provides thorough, ethical, responsive and thoughtful review of research studies. By combining impeccable review standards, savvy industry insight, responsive customer service and innovative technological solutions, Schulman creates a review experience that goes beyond the expected. We look forward to continued collaboration with our colleagues in North America and around the world as we uphold our mission to protect the rights and welfare of clinical research subjects.
Children's Medical Center is one of the leading providers in Healthcare, Pharmaceuticals, & Biotech. It is based in Dayton, OH. To find more information about Children's Medical Center, please visit www.childrensdayton.org
Knight Therapeutics Inc., headquartered in Montreal, Canada, is a specialty pharmaceutical company focused on acquiring or in-licensing innovative pharmaceutical products for the Canadian and world markets. Knight Therapeutics' shares are expected to begin trading on the TSX-V on March 3, 2014 under the symbol GUD.